Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Ocedurenone (KBP-5074) in Individuals with Moderate Hepatic Impairment

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Ocedurenone (KBP-5074) in Individuals with Moderate Hepatic Impairment ; volume:49 ; number:2 ; day:8 ; month:2 ; year:2024 ; pages:229-237 ; date:3.2024
European journal of drug metabolism and pharmacokinetics ; 49, Heft 2 (8.2.2024), 229-237, 3.2024

Urheber
McCabe, James
Zhang, Jay
Yang, Fred
Benn, Vincent
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s13318-024-00879-3
URN
urn:nbn:de:101:1-2405070913436.407793716672
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:54 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • McCabe, James
  • Zhang, Jay
  • Yang, Fred
  • Benn, Vincent
  • SpringerLink (Online service)

Ähnliche Objekte (12)

The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone

The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone

Effects of a novel non-steroidal mineralocorticoid receptor antagonist on cardiac hypertrophy

Hochschulschrift

Effects of a novel non-steroidal mineralocorticoid receptor antagonist on cardiac hypertrophy

The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction

The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction

Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists

Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists

Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease

Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers

The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception

The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception

Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis

Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis

Dose–Exposure–Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD

Dose–Exposure–Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD

Cardiovascular and Renal Outcomes with Finerenone, a Selective Mineralocorticoid Receptor Antagonist

Cardiovascular and Renal Outcomes with Finerenone, a Selective Mineralocorticoid Receptor Antagonist

The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury

Hochschulschrift

The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury

5074

Plakat / Flugblatt

5074

Verbundene Objekte